Logo image of ACET

ADICET BIO INC (ACET) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ACET - US0070021086 - Common Stock

8.28 USD
+0.34 (+4.28%)
Last: 1/16/2026, 8:00:00 PM
8.28 USD
0 (0%)
After Hours: 1/16/2026, 8:00:00 PM
Fundamental Rating

3

ACET gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While ACET has a great health rating, there are worries on its profitability. ACET is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ACET had negative earnings in the past year.
  • ACET had a negative operating cash flow in the past year.
  • ACET had negative earnings in each of the past 5 years.
  • ACET had a negative operating cash flow in each of the past 5 years.
ACET Yearly Net Income VS EBIT VS OCF VS FCFACET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • ACET has a worse Return On Assets (-72.53%) than 63.40% of its industry peers.
  • ACET has a Return On Equity of -88.63%. This is comparable to the rest of the industry: ACET outperforms 49.62% of its industry peers.
Industry RankSector Rank
ROA -72.53%
ROE -88.63%
ROIC N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ACET Yearly ROA, ROE, ROICACET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • ACET does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACET Yearly Profit, Operating, Gross MarginsACET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

More info and screens

8

2. Health

2.1 Basic Checks

  • ACET has more shares outstanding than it did 1 year ago.
  • ACET has more shares outstanding than it did 5 years ago.
  • ACET has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACET Yearly Shares OutstandingACET Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ACET Yearly Total Debt VS Total AssetsACET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ACET has an Altman-Z score of 19.20. This indicates that ACET is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 19.20, ACET belongs to the best of the industry, outperforming 88.49% of the companies in the same industry.
  • ACET has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.2
ROIC/WACCN/A
WACCN/A
ACET Yearly LT Debt VS Equity VS FCFACET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • ACET has a Current Ratio of 7.48. This indicates that ACET is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 7.48, ACET is doing good in the industry, outperforming 73.02% of the companies in the same industry.
  • A Quick Ratio of 7.48 indicates that ACET has no problem at all paying its short term obligations.
  • ACET has a Quick ratio of 7.48. This is in the better half of the industry: ACET outperforms 73.21% of its industry peers.
Industry RankSector Rank
Current Ratio 7.48
Quick Ratio 7.48
ACET Yearly Current Assets VS Current LiabilitesACET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

  • The earnings per share for ACET have decreased strongly by -798.25% in the last year.
EPS 1Y (TTM)-798.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1264.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ACET will show a very strong growth in Earnings Per Share. The EPS will grow by 28.49% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y16.14%
EPS Next 2Y17.62%
EPS Next 3Y10.39%
EPS Next 5Y28.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACET Yearly Revenue VS EstimatesACET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2028 2029 2030 2031 2032 2033 100M 200M 300M
ACET Yearly EPS VS EstimatesACET Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 -10 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • ACET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACET. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACET Price Earnings VS Forward Price EarningsACET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACET Per share dataACET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.62%
EPS Next 3Y10.39%

More info and screens

0

5. Dividend

5.1 Amount

  • ACET does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ADICET BIO INC

NASDAQ:ACET (1/16/2026, 8:00:00 PM)

After market: 8.28 0 (0%)

8.28

+0.34 (+4.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners1.6%
Inst Owner Change-0.06%
Ins Owners0.01%
Ins Owner Change0%
Market Cap1.27B
Revenue(TTM)N/A
Net Income(TTM)-118.20M
Analysts86.15
Price Target101.59 (1126.93%)
Short Float %11.01%
Short Ratio6.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.59%
Min EPS beat(2)-9.54%
Max EPS beat(2)8.37%
EPS beat(4)3
Avg EPS beat(4)3.58%
Min EPS beat(4)-9.54%
Max EPS beat(4)13.38%
EPS beat(8)6
Avg EPS beat(8)-1.85%
EPS beat(12)7
Avg EPS beat(12)-14.75%
EPS beat(16)9
Avg EPS beat(16)-3.2%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1210.53%
PT rev (3m)1560%
EPS NQ rev (1m)-1500%
EPS NQ rev (3m)-1500%
EPS NY rev (1m)1.49%
EPS NY rev (3m)8.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9.51
P/tB 9.51
EV/EBITDA N/A
EPS(TTM)-15.36
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0
BVpS0.87
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72.53%
ROE -88.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.48
Quick Ratio 7.48
Altman-Z 19.2
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)246.96%
Cap/Depr(5y)333.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-798.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1264.71%
EPS Next Y16.14%
EPS Next 2Y17.62%
EPS Next 3Y10.39%
EPS Next 5Y28.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-32.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.88%
OCF growth 3YN/A
OCF growth 5YN/A

ADICET BIO INC / ACET FAQ

What is the fundamental rating for ACET stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACET.


Can you provide the valuation status for ADICET BIO INC?

ChartMill assigns a valuation rating of 0 / 10 to ADICET BIO INC (ACET). This can be considered as Overvalued.


Can you provide the profitability details for ADICET BIO INC?

ADICET BIO INC (ACET) has a profitability rating of 0 / 10.


How financially healthy is ADICET BIO INC?

The financial health rating of ADICET BIO INC (ACET) is 8 / 10.


What is the expected EPS growth for ADICET BIO INC (ACET) stock?

The Earnings per Share (EPS) of ADICET BIO INC (ACET) is expected to grow by 16.14% in the next year.